| Income Statement |
| Operating Expenses | 46.05M |
|
| Research and Development Expense | 35.79M |
| Selling, General and Administrative Expense | 10.27M |
| Operating Income | -46.05M |
| Net Income | -44.14M |
| Net Income Common Stock | -44.14M |
| Net Income Common Stock (USD) | -44.14M |
| Consolidated Income | -44.14M |
| Earnings per Basic Share | -0.23 |
| Earnings per Basic Share (USD) | -0.23 |
| Earnings per Diluted Share | -0.23 |
| Earning Before Interest & Taxes (EBIT) | -44.14M |
| Earning Before Interest & Taxes (USD) | -44.14M |
| Weighted Average Shares | 194.20M |
| Weighted Average Shares Diluted | 194.20M |
| Balance Sheet |
| Cash and Equivalents | 176.24M |
| Cash and Equivalents (USD) | 176.24M |
| Investments | 49.82M |
| Investments Current | 49.82M |
| Current Assets | 228.27M |
| Property, Plant & Equipment Net | 24.87M |
| Total Assets | 262.89M |
| Debt Current | 3.02M |
| Total Debt | 25.43M |
| Current Liabilities | 35.94M |
| Debt Non-Current | 22.42M |
| Total Liabilities | 58.36M |
| Accumulated Retained Earnings (Deficit) | -961.53M |
| Accumulated Other Comprehensive Income | -81.00K |
| Shareholders Equity | 204.53M |
| Shareholders Equity (USD) | 204.53M |
| Assets Non-Current | 34.62M |
| Total Debt (USD) | 25.43M |
| Liabilities Non-Current | 22.42M |
| Trade and Non-Trade Payables | 17.53M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 957.00K |
| Net Cash Flow from Financing | 32.90M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 13.16M |
| Issuance (Purchase) of Equity Shares | 33.83M |
| Issuance (Repayment) of Debt Securities | -936.00K |
| Net Cash Flow from Investing | 27.06M |
| Net Cash Flow - Investment Acquisitions and Disposals | 27.06M |
| Net Cash Flow from Operations | -46.80M |
| Effect of Exchange Rate Changes on Cash | 1000 |
| Share Based Compensation | 4.16M |